The University of Chicago Header Logo

Suzanne Conzen

Concepts (456)

Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.


Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Receptors, Glucocorticoid
31
2024
135
9.410
Why?
Immediate-Early Proteins
18
2014
164
3.600
Why?
Breast Neoplasms
38
2024
3021
3.030
Why?
Mammary Neoplasms, Experimental
12
2016
127
2.080
Why?
Triple Negative Breast Neoplasms
6
2024
168
2.050
Why?
Receptors, Estrogen
11
2024
394
1.970
Why?
Glucocorticoids
8
2024
357
1.820
Why?
Paclitaxel
8
2016
474
1.670
Why?
Mammary Glands, Animal
11
2020
80
1.620
Why?
Dexamethasone
11
2015
343
1.280
Why?
Xenograft Model Antitumor Assays
6
2024
484
1.250
Why?
Apoptosis
17
2019
1717
1.190
Why?
Ovarian Neoplasms
4
2024
771
1.190
Why?
Adipose Tissue
3
2016
262
1.180
Why?
Mifepristone
6
2015
33
1.150
Why?
Gene Expression Regulation, Neoplastic
13
2024
1283
1.150
Why?
Signal Transduction
19
2024
3403
1.090
Why?
Cell Line, Tumor
17
2024
2583
1.000
Why?
Epithelial Cells
9
2018
689
0.980
Why?
Phenylthiohydantoin
3
2024
46
0.960
Why?
Prostatic Neoplasms, Castration-Resistant
2
2024
105
0.940
Why?
Benzamides
3
2024
234
0.910
Why?
Neoplasms, Glandular and Epithelial
3
2017
75
0.890
Why?
Lymphocytes, Tumor-Infiltrating
1
2024
135
0.880
Why?
Female
66
2024
46529
0.870
Why?
Carboplatin
1
2024
312
0.860
Why?
Social Isolation
4
2013
67
0.840
Why?
HSP90 Heat-Shock Proteins
2
2016
47
0.810
Why?
Animals
46
2024
27516
0.800
Why?
Cystadenocarcinoma, Serous
3
2024
51
0.790
Why?
Mice
29
2024
11846
0.790
Why?
T-Lymphocytes, Regulatory
1
2024
312
0.770
Why?
Gene Expression Profiling
7
2019
1452
0.750
Why?
Neoplasm Staging
4
2024
2000
0.750
Why?
Mastodynia
1
2020
1
0.730
Why?
Breast Cyst
1
2020
4
0.730
Why?
Tumor Microenvironment
1
2024
476
0.730
Why?
Oligonucleotide Array Sequence Analysis
7
2014
693
0.700
Why?
Neoplasm Proteins
3
2017
538
0.690
Why?
Estrogen Receptor alpha
3
2015
148
0.690
Why?
Immunohistochemistry
10
2024
1799
0.670
Why?
Antineoplastic Agents, Phytogenic
6
2013
274
0.650
Why?
Proteasome Endopeptidase Complex
4
2008
105
0.650
Why?
Humans
69
2024
89864
0.650
Why?
Gene Expression Regulation
4
2015
1983
0.650
Why?
Dual Specificity Phosphatase 1
5
2013
17
0.640
Why?
Adipocytes
3
2015
163
0.620
Why?
Magnetic Resonance Imaging
15
2019
3468
0.610
Why?
Receptors, Androgen
7
2024
119
0.590
Why?
Cell Survival
11
2018
983
0.590
Why?
Fatty Acids
2
2018
134
0.580
Why?
Drug Resistance, Neoplasm
7
2021
605
0.550
Why?
Phosphoprotein Phosphatases
3
2006
58
0.540
Why?
Chromatin
1
2019
403
0.540
Why?
Forkhead Transcription Factors
2
2008
171
0.520
Why?
Ubiquitin
2
2006
96
0.520
Why?
Carcinogenesis
4
2024
213
0.520
Why?
Phosphatidylinositol 3-Kinases
6
2012
268
0.510
Why?
Subcutaneous Fat
1
2015
22
0.510
Why?
Lysophospholipids
1
2016
66
0.510
Why?
Triazoles
1
2016
104
0.500
Why?
RNA, Messenger
10
2024
2025
0.490
Why?
Fatty Acids, Unsaturated
1
2014
28
0.460
Why?
Antineoplastic Agents
5
2018
2328
0.460
Why?
Albumins
1
2014
129
0.450
Why?
Antineoplastic Combined Chemotherapy Protocols
7
2024
2505
0.450
Why?
Hormone Antagonists
1
2013
19
0.450
Why?
Membrane Potential, Mitochondrial
1
2013
29
0.440
Why?
Nuclear Proteins
3
2004
727
0.440
Why?
Reverse Transcriptase Polymerase Chain Reaction
8
2014
885
0.440
Why?
Cell Proliferation
7
2019
1669
0.440
Why?
Mammary Neoplasms, Animal
5
2020
57
0.440
Why?
Prostatic Neoplasms
5
2021
1735
0.440
Why?
Cell Cycle Proteins
3
2004
399
0.430
Why?
Antigens, Polyomavirus Transforming
5
2015
47
0.430
Why?
Chelating Agents
1
2013
69
0.430
Why?
Magnetic Resonance Spectroscopy
1
2014
315
0.420
Why?
Calcium Signaling
1
2013
138
0.420
Why?
Pituitary-Adrenal System
1
2012
64
0.410
Why?
Receptors, Adrenergic, beta
1
2013
73
0.410
Why?
Organometallic Compounds
1
2013
137
0.410
Why?
Fluorodeoxyglucose F18
1
2013
142
0.410
Why?
Hypothalamo-Hypophyseal System
1
2012
81
0.410
Why?
Neoplasms
3
2021
3062
0.400
Why?
Breast
8
2021
292
0.400
Why?
Mice, SCID
4
2015
259
0.390
Why?
Multiprotein Complexes
2
2012
96
0.390
Why?
Receptors, Progesterone
3
2011
175
0.380
Why?
Prognosis
11
2024
3789
0.380
Why?
Up-Regulation
2
2013
726
0.370
Why?
Stress, Psychological
4
2021
322
0.370
Why?
Inflammation
2
2021
981
0.370
Why?
Carcinoma
2
2011
438
0.360
Why?
Neoplasm Recurrence, Local
6
2017
1350
0.350
Why?
Biomarkers, Tumor
5
2024
1542
0.350
Why?
Mitochondria
1
2013
555
0.340
Why?
Mitogen-Activated Protein Kinases
3
2006
226
0.340
Why?
Mutation
4
2019
4164
0.340
Why?
Cell Transformation, Neoplastic
3
2021
449
0.330
Why?
Tumor Cells, Cultured
7
2013
1048
0.330
Why?
Carcinoma, Intraductal, Noninfiltrating
5
2015
117
0.330
Why?
Receptors, Cytoplasmic and Nuclear
2
2017
122
0.330
Why?
Receptor, ErbB-2
3
2017
247
0.320
Why?
Transcription, Genetic
6
2019
1158
0.320
Why?
Proto-Oncogene Proteins c-bcl-2
4
2003
194
0.320
Why?
Calcium
1
2013
1179
0.310
Why?
Diet, High-Fat
2
2020
119
0.310
Why?
Adult
17
2024
26784
0.300
Why?
Proteins
2
2012
786
0.300
Why?
Urokinase-Type Plasminogen Activator
1
2008
51
0.300
Why?
Cell Cycle
2
2019
508
0.300
Why?
Protein Tyrosine Phosphatases
2
2004
46
0.300
Why?
Mice, Transgenic
10
2018
1576
0.300
Why?
Disease Progression
8
2021
1469
0.300
Why?
Nitriles
4
2024
156
0.290
Why?
Protein Binding
4
2019
1491
0.290
Why?
Phosphorylation
5
2012
1130
0.290
Why?
Proto-Oncogene Proteins c-akt
4
2005
341
0.280
Why?
Middle Aged
17
2024
26103
0.280
Why?
Aged
16
2024
19230
0.280
Why?
Biomarkers
1
2013
1774
0.270
Why?
Chromatin Immunoprecipitation
3
2015
137
0.260
Why?
Blotting, Western
4
2009
793
0.260
Why?
Ubiquitin-Protein Ligases
1
2006
173
0.250
Why?
Gene Expression
5
2016
1309
0.250
Why?
Transfection
5
2008
909
0.250
Why?
Carcinoma, Ductal, Breast
3
2015
160
0.240
Why?
Aged, 80 and over
8
2017
6779
0.240
Why?
Tumor Suppressor Protein p53
3
2004
412
0.240
Why?
Disease Models, Animal
6
2020
2392
0.240
Why?
Contrast Media
3
2017
1084
0.240
Why?
Neoplasm Grading
2
2024
374
0.240
Why?
Tyramine
1
2024
6
0.240
Why?
Acetates
1
2024
67
0.230
Why?
Tamoxifen
2
2003
168
0.230
Why?
Imaging, Three-Dimensional
3
2020
603
0.230
Why?
MAP Kinase Signaling System
1
2004
198
0.230
Why?
Models, Biological
3
2008
1765
0.220
Why?
Selective Estrogen Receptor Modulators
2
2003
34
0.220
Why?
MCF-7 Cells
2
2015
114
0.220
Why?
Real-Time Polymerase Chain Reaction
2
2016
283
0.220
Why?
Enzyme Activation
4
2012
696
0.220
Why?
Caspase 3
2
2013
162
0.220
Why?
COS Cells
3
2008
167
0.210
Why?
Enzyme Induction
3
2013
88
0.210
Why?
Enhancer Elements, Genetic
2
2019
284
0.210
Why?
Ubiquitins
1
2002
38
0.210
Why?
Cell Line
7
2009
2495
0.200
Why?
Genomics
2
2019
776
0.200
Why?
Estradiol
1
2003
250
0.200
Why?
RNA, Small Interfering
4
2018
557
0.190
Why?
Adrenergic beta-Antagonists
2
2013
105
0.190
Why?
Proton Magnetic Resonance Spectroscopy
2
2018
12
0.190
Why?
Sirolimus
2
2012
162
0.180
Why?
Down-Regulation
3
2008
520
0.180
Why?
Genes, myc
1
2000
40
0.180
Why?
Cells, Cultured
3
2015
2887
0.180
Why?
Simian virus 40
2
2015
35
0.180
Why?
Disease-Free Survival
5
2017
1168
0.180
Why?
Proto-Oncogene Proteins
5
2004
665
0.170
Why?
Mammography
2
2020
475
0.170
Why?
Gene Expression Regulation, Enzymologic
1
2001
217
0.170
Why?
Transcription Factors
2
2004
1665
0.170
Why?
Arteries
1
2020
179
0.160
Why?
Transplantation, Heterologous
2
2013
368
0.160
Why?
Antineoplastic Agents, Hormonal
2
2012
145
0.160
Why?
Gadolinium DTPA
2
2017
256
0.160
Why?
Random Allocation
2
2018
327
0.160
Why?
Arabidopsis Proteins
1
2000
138
0.150
Why?
Biopsy
2
2020
1184
0.150
Why?
Dietary Sugars
1
2018
8
0.150
Why?
Megestrol Acetate
1
2017
10
0.150
Why?
Diet, Fat-Restricted
1
2018
31
0.150
Why?
Chemotherapy, Adjuvant
3
2017
476
0.150
Why?
Continuity of Patient Care
1
2019
172
0.150
Why?
Magnetic Resonance Angiography
1
2020
275
0.150
Why?
Feeding Behavior
1
2020
328
0.150
Why?
Forkhead Box Protein O3
2
2008
21
0.140
Why?
Metabolome
1
2017
51
0.140
Why?
Immunoenzyme Techniques
2
2008
303
0.140
Why?
TNF-Related Apoptosis-Inducing Ligand
2
2006
25
0.140
Why?
Small Molecule Libraries
1
2017
65
0.140
Why?
Dietary Fats
1
2017
135
0.140
Why?
Rats
7
2018
4048
0.130
Why?
Neoplasm Invasiveness
5
2020
569
0.130
Why?
Interdisciplinary Communication
2
2010
131
0.130
Why?
Response Elements
1
2016
69
0.130
Why?
Algorithms
1
2004
1908
0.130
Why?
Transcriptome
2
2018
661
0.130
Why?
Protein Processing, Post-Translational
2
2012
383
0.130
Why?
Binding Sites
2
2009
1121
0.130
Why?
Culture Media, Conditioned
1
2016
103
0.130
Why?
Amino Acid Motifs
2
2006
117
0.130
Why?
Drug Synergism
1
2016
307
0.120
Why?
Luciferases
2
2006
128
0.120
Why?
Embryo, Mammalian
1
1995
223
0.120
Why?
Biomedical Research
1
2019
403
0.120
Why?
Carcinoma in Situ
1
2015
52
0.120
Why?
Carcinoma, Lobular
1
2015
81
0.120
Why?
Lymph Nodes
2
2015
550
0.120
Why?
Image Processing, Computer-Assisted
3
2015
1255
0.120
Why?
Endoplasmic Reticulum
2
2006
255
0.120
Why?
Endometrial Neoplasms
1
2017
208
0.120
Why?
Poly(ADP-ribose) Polymerases
2
2013
51
0.120
Why?
Coconut Oil
1
2014
4
0.120
Why?
Plant Oils
1
2014
9
0.120
Why?
Protein Phosphatase 1
2
2004
34
0.120
Why?
Fibroblasts
3
2006
759
0.120
Why?
Cell Death
1
2015
261
0.120
Why?
Caspase 7
1
2013
15
0.110
Why?
Mitochondrial Membranes
1
2013
15
0.110
Why?
Caloric Tests
1
2013
6
0.110
Why?
Genetic Testing
1
2017
541
0.110
Why?
Lipogenesis
1
2013
23
0.110
Why?
Cell Differentiation
2
2018
1532
0.110
Why?
Necrosis
1
2013
210
0.110
Why?
Leptin
1
2013
102
0.110
Why?
Neoplasm Transplantation
1
2013
397
0.100
Why?
Healthcare Disparities
1
2017
431
0.100
Why?
Furans
1
2012
16
0.100
Why?
Mechanistic Target of Rapamycin Complex 2
1
2012
11
0.100
Why?
Food
1
2013
89
0.100
Why?
Enzyme Activators
1
2012
14
0.100
Why?
Thapsigargin
1
2012
55
0.100
Why?
Male
7
2024
42614
0.100
Why?
Mechanistic Target of Rapamycin Complex 1
1
2012
29
0.100
Why?
Hypothalamus
1
2012
79
0.100
Why?
Enzyme-Linked Immunosorbent Assay
1
2013
374
0.100
Why?
Time Factors
4
2012
5357
0.100
Why?
Sequence Analysis, DNA
1
2015
869
0.100
Why?
Positron-Emission Tomography
1
2013
337
0.090
Why?
Neoplasms, Hormone-Dependent
1
2011
36
0.090
Why?
TOR Serine-Threonine Kinases
1
2012
188
0.090
Why?
Tissue Array Analysis
1
2011
126
0.090
Why?
bcl-X Protein
3
2006
53
0.090
Why?
Cyclins
2
2004
82
0.090
Why?
Chromones
2
2008
31
0.090
Why?
Anti-Inflammatory Agents
1
2013
346
0.090
Why?
Cyclin-Dependent Kinase Inhibitor p21
2
2004
79
0.090
Why?
Stress, Physiological
2
2009
232
0.090
Why?
Promoter Regions, Genetic
2
2018
961
0.090
Why?
Morpholines
2
2008
70
0.090
Why?
Pyridines
1
2012
300
0.090
Why?
Glucose
1
2013
629
0.090
Why?
Group Processes
1
2010
31
0.090
Why?
Community-Institutional Relations
1
2010
29
0.090
Why?
Neoplasm Metastasis
3
2017
1066
0.090
Why?
Models, Molecular
1
2014
1315
0.080
Why?
Pyrimidines
1
2012
371
0.080
Why?
Octamer Transcription Factor-1
1
2009
19
0.080
Why?
Dose-Response Relationship, Drug
1
2013
1929
0.080
Why?
Neurosecretory Systems
1
2009
36
0.080
Why?
Gadolinium
1
2009
103
0.080
Why?
Endocrine Gland Neoplasms
1
2009
6
0.080
Why?
Placebos
1
2009
211
0.080
Why?
Enzyme Inhibitors
3
2008
644
0.080
Why?
Adenocarcinoma, Clear Cell
1
2009
61
0.080
Why?
MAP Kinase Kinase 4
2
2008
64
0.080
Why?
Amino Acid Sequence
2
2006
2063
0.080
Why?
p38 Mitogen-Activated Protein Kinases
2
2008
125
0.080
Why?
Nuclear Receptor Coactivator 3
1
2008
5
0.080
Why?
Lactams, Macrocyclic
1
2008
13
0.080
Why?
Protein-Energy Malnutrition
1
1988
4
0.080
Why?
Peroxisome Proliferator-Activated Receptors
1
2008
7
0.080
Why?
Benzoquinones
1
2008
26
0.080
Why?
Recombinant Proteins
2
2017
1008
0.080
Why?
Receptors, Retinoic Acid
1
2008
47
0.080
Why?
Histone Acetyltransferases
1
2008
42
0.080
Why?
Precancerous Conditions
1
2009
200
0.080
Why?
Mammary Glands, Human
1
2008
24
0.080
Why?
Social Environment
2
2009
187
0.070
Why?
Health Status Disparities
1
2010
191
0.070
Why?
Molecular Sequence Data
2
2006
3024
0.070
Why?
Carcinoma, Papillary
1
2009
156
0.070
Why?
Protein Kinase Inhibitors
1
2012
586
0.070
Why?
Tumor Burden
2
2020
310
0.070
Why?
Kinetics
2
2017
1534
0.070
Why?
Antigen-Presenting Cells
1
1988
142
0.070
Why?
Reperfusion Injury
1
2008
144
0.070
Why?
Conserved Sequence
1
2008
211
0.070
Why?
Retrospective Studies
4
2017
9185
0.070
Why?
Gene Frequency
1
2009
687
0.070
Why?
Insulin
1
2012
1148
0.070
Why?
Mice, Knockout
2
2015
2015
0.070
Why?
Receptors, Calcitriol
1
2008
130
0.070
Why?
Mice, Inbred C57BL
1
2014
3250
0.070
Why?
Carcinoma, Papillary, Follicular
1
2006
14
0.070
Why?
BH3 Interacting Domain Death Agonist Protein
1
2006
13
0.070
Why?
Lymphatic Metastasis
1
2008
495
0.070
Why?
Insulin-Like Growth Factor Binding Protein 3
1
2006
21
0.070
Why?
In Situ Nick-End Labeling
1
2006
122
0.070
Why?
Phenotype
3
2019
2450
0.070
Why?
Catalytic Domain
1
2006
156
0.070
Why?
Injections
2
2017
116
0.060
Why?
Alleles
1
2009
1139
0.060
Why?
Young Adult
3
2017
6389
0.060
Why?
Fluorescent Antibody Technique
1
2006
323
0.060
Why?
Base Sequence
1
2009
2329
0.060
Why?
Trans-Activators
1
2008
443
0.060
Why?
DNA Primers
1
2006
543
0.060
Why?
ets-Domain Protein Elk-1
1
2004
8
0.060
Why?
Mitogen-Activated Protein Kinase 3
1
2004
70
0.060
Why?
Mitogen-Activated Protein Kinase 1
1
2004
77
0.060
Why?
Blotting, Northern
1
2004
258
0.060
Why?
JNK Mitogen-Activated Protein Kinases
1
2004
112
0.060
Why?
Flow Cytometry
1
2006
690
0.060
Why?
Mitogen-Activated Protein Kinase Kinases
1
2004
98
0.060
Why?
Survival Rate
2
2019
1898
0.060
Why?
Genes, Reporter
1
2004
274
0.060
Why?
Liver
1
2008
1211
0.060
Why?
Mice, Nude
2
2017
816
0.060
Why?
Age Factors
1
2008
1880
0.060
Why?
DNA
1
2009
1311
0.050
Why?
Benzopyrans
1
2003
12
0.050
Why?
Estrogen Receptor Modulators
1
2003
10
0.050
Why?
Epidermal Growth Factor
1
2003
117
0.050
Why?
Tissue Plasminogen Activator
1
2004
173
0.050
Why?
Propionates
1
2003
33
0.050
Why?
Estrogen Antagonists
1
2003
48
0.050
Why?
Thiophenes
1
2003
43
0.050
Why?
Proto-Oncogene Proteins c-myc
1
2003
126
0.050
Why?
Computational Biology
1
2006
551
0.050
Why?
Cysteine Proteinase Inhibitors
1
2002
53
0.050
Why?
Multienzyme Complexes
1
2002
64
0.050
Why?
Bayes Theorem
1
2004
381
0.050
Why?
Cysteine Endopeptidases
1
2002
87
0.050
Why?
Genetic Variation
1
2009
1380
0.050
Why?
Molecular Structure
1
2003
293
0.050
Why?
Thyroid Neoplasms
1
2006
425
0.050
Why?
Psychophysiology
1
2021
6
0.050
Why?
Rats, Sprague-Dawley
2
2018
1237
0.050
Why?
Piperidines
1
2003
163
0.050
Why?
Saccharomyces cerevisiae Proteins
1
2004
286
0.050
Why?
Transcriptional Activation
1
2002
294
0.050
Why?
Oncogene Addiction
1
2021
2
0.050
Why?
Liver Transplantation
1
2008
1175
0.050
Why?
Saccharomyces cerevisiae
1
2004
440
0.050
Why?
Indoles
1
2003
300
0.050
Why?
Growth Substances
1
2001
79
0.050
Why?
Hormones
1
2021
139
0.050
Why?
Models, Statistical
1
2004
576
0.050
Why?
Polymorphism, Single Nucleotide
1
2009
2414
0.050
Why?
Microscopy, Fluorescence
2
2014
434
0.040
Why?
Fatty Acid Desaturases
1
2000
17
0.040
Why?
Genetic Predisposition to Disease
1
2009
2360
0.040
Why?
Regional Blood Flow
1
2020
198
0.040
Why?
Computer Simulation
1
2004
1101
0.040
Why?
fas Receptor
1
2000
77
0.040
Why?
Risk
1
2021
657
0.040
Why?
Organ Size
1
2020
372
0.040
Why?
DNA Damage
1
2021
373
0.040
Why?
Cell Membrane
1
2002
677
0.040
Why?
DNA Repair
1
2021
363
0.040
Why?
Risk Factors
3
2021
5548
0.040
Why?
DNA-Binding Proteins
1
2004
1244
0.040
Why?
Germ-Line Mutation
1
2021
347
0.040
Why?
Troleandomycin
1
2017
3
0.040
Why?
Cytochrome P-450 CYP3A Inhibitors
1
2017
5
0.040
Why?
Glucuronides
1
2017
34
0.040
Why?
Cancer Survivors
1
2019
95
0.040
Why?
Cytochrome P-450 CYP3A
1
2017
42
0.040
Why?
Ketoconazole
1
2017
24
0.040
Why?
Microsomes, Liver
1
2017
49
0.040
Why?
Fructose
1
2018
36
0.040
Why?
Datasets as Topic
1
2017
75
0.040
Why?
Weaning
1
2017
25
0.040
Why?
Clinical Trials as Topic
1
2003
1134
0.040
Why?
bcl-2-Associated X Protein
1
1997
46
0.040
Why?
Adiposity
1
2017
76
0.030
Why?
Epigenesis, Genetic
1
2021
521
0.030
Why?
Substrate Specificity
1
2017
352
0.030
Why?
Remission Induction
2
2011
740
0.030
Why?
Phosphotransferases (Alcohol Group Acceptor)
1
1997
80
0.030
Why?
Combined Modality Therapy
3
2006
1704
0.030
Why?
Mitoxantrone
1
1996
67
0.030
Why?
Oxidation-Reduction
1
2017
388
0.030
Why?
Structure-Activity Relationship
1
1997
414
0.030
Why?
Predictive Value of Tests
2
2016
1729
0.030
Why?
Etoposide
1
1996
206
0.030
Why?
Guideline Adherence
1
2017
234
0.030
Why?
Genes, BRCA1
1
1996
192
0.030
Why?
Prostate-Specific Antigen
1
2017
338
0.030
Why?
Alternative Splicing
1
1996
212
0.030
Why?
BRCA1 Protein
1
1996
205
0.030
Why?
Cellular Senescence
1
1995
100
0.030
Why?
Patient Acceptance of Health Care
1
2017
260
0.030
Why?
Survival Analysis
1
2018
1497
0.030
Why?
Longitudinal Studies
1
2018
1083
0.030
Why?
Metribolone
1
2014
5
0.030
Why?
Cisplatin
1
1996
598
0.030
Why?
Androgen Receptor Antagonists
1
2014
20
0.030
Why?
Cell Division
1
1995
692
0.030
Why?
Benzoates
1
2014
33
0.030
Why?
Signal-To-Noise Ratio
1
2014
104
0.030
Why?
Databases, Factual
1
2017
864
0.030
Why?
Immunoblotting
1
2014
272
0.030
Why?
Bridged Bicyclo Compounds, Heterocyclic
1
2014
91
0.030
Why?
ROC Curve
1
2015
778
0.030
Why?
Perfusion
1
2014
253
0.030
Why?
Registries
1
2017
803
0.030
Why?
RNA Interference
1
2014
376
0.030
Why?
Image Enhancement
1
2016
565
0.030
Why?
HEK293 Cells
1
2014
646
0.020
Why?
Image Interpretation, Computer-Assisted
1
2016
691
0.020
Why?
Interinstitutional Relations
1
2010
29
0.020
Why?
Endocrine Glands
1
2009
13
0.020
Why?
Diabetes Complications
1
2011
171
0.020
Why?
Corticosterone
1
2009
35
0.020
Why?
United States
2
2017
7094
0.020
Why?
Health Services Research
1
2010
138
0.020
Why?
Interprofessional Relations
1
2010
121
0.020
Why?
Subtraction Technique
1
2009
130
0.020
Why?
Reproducibility of Results
1
2015
2766
0.020
Why?
Cooperative Behavior
1
2010
179
0.020
Why?
Treatment Outcome
2
2012
8264
0.020
Why?
Risk Assessment
1
2016
2324
0.020
Why?
Ovary
1
2009
262
0.020
Why?
Microscopy
1
2008
87
0.020
Why?
Interleukin-1
1
1988
72
0.020
Why?
Recurrence
1
2011
1144
0.020
Why?
Neoadjuvant Therapy
1
2011
376
0.020
Why?
Ovalbumin
1
1988
109
0.020
Why?
Mice, Inbred Strains
1
1988
308
0.020
Why?
Histocompatibility Antigens Class II
1
1988
166
0.020
Why?
Spleen
1
1988
433
0.020
Why?
Behavior, Animal
1
2009
380
0.020
Why?
Feasibility Studies
1
2008
785
0.020
Why?
Pilot Projects
1
2009
871
0.020
Why?
Radiodermatitis
1
2005
10
0.020
Why?
Hypertension
1
2011
747
0.020
Why?
Lymphocyte Activation
1
1988
754
0.020
Why?
Chronic Disease
1
1988
958
0.010
Why?
Carcinoma, Hepatocellular
1
2008
399
0.010
Why?
Arousal
1
2005
170
0.010
Why?
Data Interpretation, Statistical
1
2006
302
0.010
Why?
Diabetes Mellitus
1
2011
744
0.010
Why?
Butadienes
1
2003
34
0.010
Why?
Mammaplasty
1
2005
110
0.010
Why?
B-Lymphocytes
1
1988
740
0.010
Why?
Genes, erbB-2
1
2003
25
0.010
Why?
Receptors, Steroid
1
2003
42
0.010
Why?
Wound Healing
1
2005
361
0.010
Why?
Liver Neoplasms
1
2008
755
0.010
Why?
Quinazolines
1
2003
212
0.010
Why?
Phytotherapy
1
2003
136
0.010
Why?
Research
1
2003
251
0.010
Why?
T-Lymphocytes
1
1988
1221
0.010
Why?
Cytokines
1
2003
811
0.010
Why?
Oncogene Protein pp60(v-src)
1
1997
3
0.010
Why?
Poly (ADP-Ribose) Polymerase-1
1
1997
25
0.010
Why?
Proto-Oncogene Proteins c-raf
1
1997
48
0.010
Why?
Receptors, Growth Factor
1
1997
52
0.010
Why?
Androstadienes
1
1997
72
0.010
Why?
ras Proteins
1
1997
130
0.010
Why?
Exons
1
1996
453
0.010
Why?
Polymerase Chain Reaction
1
1996
919
0.010
Why?
Conzen's Networks
Click the
Explore
buttons for more information and interactive visualizations!
Concepts (456)
Explore
_
Co-Authors (47)
Explore
_
Similar People (60)
Explore
_
Physical Neighbors
_